Mar 18, 2021 / 08:30PM GMT
Operator
Ladies and gentlemen, thank you for standing by, and welcome to Salarius Pharmaceuticals Q4 and Year-end 2020 Financial Results Call. (Operator Instructions) Please be advised that today's conference may be recorded. (Operator Instructions)
I would now like to hand the conference over to your host, Jason Rando with Tiberend Strategic Advisors. Sir, please go ahead.
Jason Rando - Tiberend Strategic Advisors, Inc. - COO & EVP
Good afternoon, everyone, and thank you for joining Salarius Pharmaceuticals 2020 Fourth Quarter and Full Year Financial and Corporate Results Call. Earlier this afternoon, Salarius Pharmaceuticals issued a press release detailing its financial results for the 3 months and the full year ended December 31, 2020, which we encourage listeners to read. The press release can be found in the News section of salariuspharma.com. Salarius also filed a 10-K this afternoon, which is available on Salariuspharma.com and sec.gov.
Before beginning today's call, I would like to make the following statement. Today, we'll be making
Q4 2020 Salarius Pharmaceuticals Inc Earnings Call Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers